Vasopressin-2 receptor antagonist attenuates the ability of the lungs to clear edema in an experimental model

American Journal of Respiratory Cell and Molecular Biology

Volumn 47, Issue 5, 2012, Pages 583-588

  Guetta, Julia ^a   Klorin, Geula ^a   Tal, Ronit ^a   Berger, Gidon ^a,b   Ismael Badarneh, Reem ^a   Bishara, Bishara ^a,b   Sabo, Edmond ^a,b   Abassi, Zaid ^b   Azzam, Zaher S ^a,b  

^a Legacy Heritage Clinical Research Institute at Rambam   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Active sodium; Alveolar fluid clearance; Na,K ATPase; V2 receptor; Vasopressin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); RELCOVAPTAN; SATAVAPTAN; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

ALVEOLAR FLUID CLEARANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; CONTROLLED STUDY; INTRACELLULAR SIGNALING; LUNG ALVEOLUS EPITHELIUM; LUNG CLEARANCE; LUNG EDEMA; LUNG FLUID; MALE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN CONTENT; RAT; RECEPTOR UPREGULATION; SODIUM TRANSPORT;

AMILORIDE; ANIMALS; CELLS, CULTURED; COLCHICINE; INDOLES; MALE; MORPHOLINES; OUABAIN; PERMEABILITY; PNEUMOCYTES; PULMONARY ALVEOLI; PULMONARY EDEMA; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; SODIUM-POTASSIUM-EXCHANGING ATPASE; SPIRO COMPOUNDS; VASOPRESSINS;

RATTUS; STROPHANTHUS GRATUS;

EID: 84868328404     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0117OC     Document Type: Article

References (39)

1. Azzam ZS, Sznajder JI. The cellular mechanisms contributing to lung edema clearance. Isr Med Assoc J 2000;2:235-239.
2. Matthay MA, Folkesson HG, Verkman AS. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol 1996;270:L487-L503.
3. Matalon S. Mechanisms and regulation of ion transport in adult mammalian alveolar type ii pneumocytes. Am J Physiol 1991;261:C727-C738.
4. Kannel WB. Current status of the epidemiology of heart failure. Curr Cardiol Rep 1999;1:11-19.
5. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-2018.
6. Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN. The neurohumoral axis in congestive heart failure. Ann Intern Med 1984; 101:370-377.
7. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248-254.
8. Robertson GL. Physiology of adh secretion. Kidney Int Suppl 1987;21: S20-S26.
9. Birnbaumer M. Vasopressin receptors. Trends Endocrinol Metab 2000; 11:406-410.
10. Bankir L. Antidiuretic action of vasopressin: quantitative aspects and interaction between v1a and v2 receptor-mediated effects. Cardiovasc Res 2001;51:372-390.
11. Cassin S, Perks AM. Amiloride inhibits arginine vasopressin-induced decrease in fetal lung liquid secretion. J Appl Physiol 1993;75:1925-1929.
12. Perks AM, Cassin S. The effects of arginine vasopressin and epinephrine on lung liquid production in fetal goats. Can J Physiol Pharmacol 1989;67:491-498.
13. Elias N, Rafii B, Rahman M, Otulakowski G, Cutz E, O'Brodovich H. The role of alpha-, beta-, and gamma-enac subunits in distal lung epithelial fluid absorption induced by pulmonary edema fluid. Am J Physiol Lung Cell Mol Physiol 2007;293:L537-L545.
14. Hochberg I, Abassi Z, Azzam ZS. Patterns of alveolar fluid clearance in heart failure. Int J Cardiol 2008;130:125-130.
15. Azzam ZS, Adir Y, Welch L, Chen J, Winaver J, Factor P, Krivoy N, Hoffman A, Sznajder JI, Abassi Z. Alveolar fluid reabsorption is increased in rats with compensated heart failure. Am J Physiol Lung Cell Mol Physiol 2006;291:L1094-L1100.
16. Rutschman DH, Olivera W, Sznajder JI. Active transport and passive liquid movement in isolated perfused rat lungs. J Appl Physiol 1993; 75:1574-1580.
17. Dobbs LG. Isolation and culture of alveolar type ii cells. Am J Physiol 1990;258:L134-L147.
18. Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Zampino M, Orlandi C. Vasopressin v2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation 2003;107:2690-2696.
19. Yancy CW. Climbing the mountain of acute decompensated heart failure: the Everest trials. JAMA 2007;297:1374-1376.
20. Westphal M, Rehberg S, Maybauer MO, Maybauer DM, Enkhbaatar P, Westphal-Varghese BB, Schmalstieg FC, Morita N, Cox RA, Traber LD, et al. Cardiopulmonary effects of low-dose arginine vasopressin in ovine acute lung injury. Crit Care Med 2011;39:357-363.
21. Wallace MJ, Hooper SB, Harding R. Regulation of lung liquid secretion by arginine vasopressin in fetal sheep. Am J Physiol 1990;258:R104-R111.
22. Fay MJ, Du J, Yu X, North WG. Evidence for expression of vasopressin v2 receptor mrna in human lung. Peptides 1996;17:477-481.
23. Albuquerque CA, Nijland MJ, Ross MG. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of v2- receptor effect. J Matern Fetal Med 1998;7:177-182.
24. Matalon S, O'Brodovich H. Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance. Annu Rev Physiol 1999;61:627-661.
25. Azzam ZS, Adir Y, Crespo A, Comellas A, Lecuona E, Dada LA, Krivoy N, Rutschman DH, Sznajder JI, Ridge KM. Norepinephrine increases alveolar fluid reabsorption and na,k-atpase activity. Am J Respir Crit Care Med 2004;170:730-736.
26. Sznajder JI, Olivera WG. New prospects in the clearance of pulmonary edema. Arch Bronconeumol 1997;33:207-209.
27. Barnard ML, Olivera WG, Rutschman DM, Bertorello AM, Katz AI, Sznajder JI. Dopamine stimulates sodium transport and liquid clearance in rat lung epithelium. Am J Respir Crit Care Med 1997;156:709-714.
28. Bertorello AM, Katz AI. Regulation of na+-k+ pump activity: pathways between receptors and effectors. News Physiol Sci 1995;10:253-259.
29. Saldias F, Lecuona E, Friedman E, Barnard ML, Ridge KM, Sznajder JI. Modulation of lung liquid clearance by isoproterenol in rat lungs. Am J Physiol 1998;274:L694-L701.
30. Saldias FJ, Comellas AP, Pesce L, Lecuona E, Sznajder JI. Dopamine increases lung liquid clearance during mechanical ventilation. Am J Physiol Lung Cell Mol Physiol 2002;283:L136-L143.
31. Saldias FJ, Lecuona E, Comellas AP, Ridge KM, Sznajder JI. Dopamine restores lung ability to clear edema in rats exposed to hyperoxia. Am J Respir Crit Care Med 1999;159:626-633.
32. Sartori C, Fang X, McGraw DW, Koch P, Snider ME, Folkesson HG, Matthay MA. Selected contribution: long-term effects of beta(2)-adrenergic receptor stimulation on alveolar fluid clearance in mice. J Appl Physiol 2002;93:1875-1880.
33. Smith PR, Saccomani G, Joe EH, Angelides KJ, Benos DJ. Amiloridesensitive sodium channel is linked to the cytoskeleton in renal epithelial cells. Proc Natl Acad Sci USA 1991;88:6971-6975.
34. Ishikawa SE, Schrier RW. Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion. Clin Endocrinol (Oxf) 2003;58:1-17.
35. Bankir L, Bichet DG, Bouby N. Vasopressin v2 receptors, enac, and sodium reabsorption: a risk factor for hypertension? Am J Physiol Renal Physiol 2010;299:F917-F928.
36. Boulkroun S, Ruffieux-Daidie D, Vitagliano JJ, Poirot O, Charles RP, Lagnaz D, Firsov D, Kellenberger S, Staub O. Vasopressin-inducible ubiquitin-specific protease 10 increases enac cell surface expression by deubiquitylating and stabilizing sorting nexin 3. Am J Physiol Renal Physiol 2008;295:F889-F900.
37. Bugaj V, Pochynyuk O, Stockand JD. Activation of the epithelial na+ channel in the collecting duct by vasopressin contributes to water reabsorption. Am J Physiol Renal Physiol 2009;297:F1411-F1418.
38. Kaestle SM, Reich CA, Yin N, Habazettl H, Weimann J, Kuebler WM. Nitric oxide-dependent inhibition of alveolar fluid clearance in hydrostatic lung edema. Am J Physiol Lung Cell Mol Physiol 2007;293: L859-L869.
39. Comellas AP, Briva A, Dada LA, Butti ML, Trejo HE, Yshii C, Azzam ZS, Litvan J, Chen J, Lecuona E, et al. Endothelin-1 impairs alveolar epithelial function via endothelial etb receptor. Am J Respir Crit Care Med 2009;179:113-122.